AR and Familial prostate cancer: Leveraging our library of ARTADIs using cultured prostate cancer cells and multiple xenograft models, we reveal that small alterations in the chemical scaffold impact selectivity and potency within the AR-transcriptome; impacting signal transduction pathways involved in protumorigenic mechanisms.